Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Itraconazole in cyclodextrin solution.

D A Stevens1

  • 1Department of Medicine, Santa Clara Valley Medical Center, and California Institute for Medical Research, San Jose 95128-2699, USA.

Pharmacotherapy
|May 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular epidemiology of global Candida dubliniensis isolates utilizing genomic-wide, co-dominant, PCR-based markers for strain delineation.

Medical mycology·2009
Same author

In vitro activity of amphotericin B against Aspergillus terreus isolates from different countries and regions.

Journal of chemotherapy (Florence, Italy)·2009
Same author

Frequency of paradoxical effect with caspofungin in Candida albicans.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2009
Same author

Conventional or molecular measurement of Aspergillus load.

Medical mycology·2008
Same author

Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Clinical and experimental immunology·2006
Same author

The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.

Medical mycology·2005
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

This study shows that formulating itraconazole (an antifungal) with cyclodextrin enhances its absorption. This new formulation improves drug delivery, potentially increasing efficacy for various conditions, especially in patients with absorption issues.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Mycology

Background:

  • Itraconazole is a poorly water-soluble triazole antifungal agent.
  • Oral itraconazole formulations have shown variable absorption, particularly in patients with gastrointestinal disorders.
  • Cyclodextrins are known complexing agents capable of enhancing the solubility and bioavailability of lipophilic drugs.

Purpose of the Study:

  • To develop and evaluate a novel cyclodextrin-based formulation of itraconazole.
  • To assess the impact of cyclodextrin complexation on itraconazole's solubility and absorption characteristics.
  • To explore the potential for improved therapeutic efficacy of the new itraconazole formulation.

Main Methods:

  • Itraconazole was formulated as a solution using cyclodextrin.

Related Experiment Videos

  • The formulation's ability to solubilize itraconazole was characterized.
  • The absorption enhancement mechanism involving the lipid interface of the gut lumen was described.

    • Main Results:

    • The cyclodextrin formulation significantly enhanced the solubility and absorption of itraconazole.
    • The complexation allows for drug delivery to the gut lumen's lipid interface.
    • The formulation avoids the absorption of the cyclodextrin ring itself.

    Conclusions:

    • Cyclodextrin complexation represents a promising strategy for improving oral itraconazole delivery.
    • Enhanced itraconazole absorption is expected to lead to improved blood and tissue levels.
    • This novel formulation holds potential for greater efficacy in treating mucosal diseases, including in patients with compromised gastrointestinal absorption.